Medications

Breast cancer: New drug shrinks brain metastases

An Austrian study led by MedUni Vienna showed that active brain metastases in breast cancer patients are partially or even completely regressed by a novel class of drug. This is a chemical conjugate of an antibody and a chemotherapy ...

Oncology & Cancer

Fighting racial bias in next-gen breast cancer screening

Breast cancer is one of the most common and deadly types of cancer, and the best outcomes stem from early detection. But some screening techniques may be less effective for people with darker skin.

page 7 from 40